Application of tekaning (Chinese character) in preparation of mitochondrial injury protective agent

A protective agent and mitochondrial technology, which is applied in the application field of tecanin in the preparation of drugs for inhibiting mitochondrial damage, food or health products, and can solve problems such as Parkinson's disease, nerve cell apoptosis and necrosis

CN103877094AInactive Publication Date: 2014-06-25何蓉蓉
1 Cites 7 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2014-06-25
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses application of a compound tekaning (Chinese character) with a structure in a formula (I) in the specification in preparation of a mitochondrial injury protective agent. In addition, the invention also discloses the mitochondrial injury protective agent of which the effective component is the compound tekaning with the structure in the formula (I). The application fully proves that the compound tekaning, and drugs, drinks or health products containing effective components of the compound tekaning can be used for effectively promoting expression of mitochondrial autophagy key signal molecules, and enhancing mitochondrial autophagy to inhibit the mitochondrial injury, so as to effectively clear mitochondrial dysfunction existing in cortical neuron, especially, dopaminergic neurons of the brain of which the mitochondrial mass is relatively low. Thus, the dopaminergic neuron is protected to play the roles of relieving parkinson's disease and the like and treating a nerve disease.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to the use of a compound Theacrine, in particular to the use of Theacrine in the preparation of drugs for inhibiting mitochondrial damage, food or health products. Background technique

[0002] Parkinson's disease (PD) is a common neurodegenerative disease that can impair the motor function, language and writing abilities of patients. According to epidemiological statistics, the number of patients with Parkinson's disease in the world was 4.5 million in 2005. With the aging population, the incidence rate is increasing year by year, and the number of patients will increase to 9 million by 2030. Parkinson's disease has seriously troubled the quality of life of patients and brought heavy family and social burdens. Therefore, research on the treatment of Parkinson's disease has important social significance and broad market prospects. The pathological mechanism of Parkinson's disease is related to the selective necrosis of do...

Examples

Embodiment 1

[0029] Preparation of Teacrine dripping pills: Take 5.0g of the real compound Theacrine, mix well with 60009.5g of polyethylene glycol, melt at 80°C, cool in simethicone oil, drop into pills, Obtain 100 drop pills.

Embodiment 2

[0031] Preparation of Teacrine soft capsules: take 5.0 g of the real compound Theacrine, mix well with 45.0 g of vegetable oil, and send it into a soft capsule packaging machine to obtain 100 soft capsules.

Embodiment 3

[0033] Preparation of Teacrine Tablets: Take 5.0 g of the real compound Theacrine, add starch solution, granulate, compress into tablets, and pack separately to obtain 100 tablets.